• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TF-21A
Device Problem Device Stenosis (4066)
Patient Problem Aortic Valve Stenosis (1717)
Event Date 03/19/2024
Event Type  Injury  
Manufacturer Narrative
Literature article attached: "enhancing transcatheter aortic valve implantation (tavi) outcomes through virtual proctoring: a case series analysis", investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
The article, "enhancing transcatheter aortic valve implantation (tavi) outcomes through virtual proctoring: a case series analysis", was reviewed.The article presented a case study of an 82-year-old female patient.It was reported that on an unknown date, a 21mm trifecta valve was implanted.It was then reported on an unknown date, the patient presented with severe aortic valve stenosis and a decision was made to perform a transcatheter valve-in-valve procedure with concomitant coronary protection.[the primary and corresponding author was claudiu ungureanu, department of cardiology, jolimont hospital, la louvière, belgium, with corresponding email: claudiu.Ungureanu@jolimont.Be].
 
Manufacturer Narrative
As reported in a research article, enhancing transcatheter aortic valve implantation (tavi) outcomes through virtual proctoring: a case series analysis.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.Literature attachment: article title: enhancing transcatheter aortic valve implantation (tavi) outcomes through virtual proctoring: a case series analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19099814
MDR Text Key340104583
Report Number2135147-2024-01677
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberTF-21A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/20/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received04/22/2024
Supplement Dates FDA Received05/02/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
Patient SexFemale
-
-